Ran Sun
Hefei, 230032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Knockout of Trpc6 attenuates T2DM-induced liver injury and inflammation by inhibiting CN-NFAT2-NLRP3 signalling in mice.
Journal: Pathology, research and practice
Published: April 23, 2024
Corrigendum to "Trpc6 knockout improves behavioral dysfunction and reduces Aβ production by inhibiting CN-NFAT1 signaling in T2DM mice" [Experimental Neurology 363 (2023) 114350/manuscript number: EXNR-22-846].
Journal: Experimental neurology
Published: March 29, 2024
Two new acorane-type sesquiterpenoids from an endophytic Trichoderma harzianum associated with Paeonia lactiflora Pall.
Journal: Natural product research
Published: February 01, 2024
Corrigendum to "Ginsenoside Rg1 attenuates LPS-induced chronic renal injury by inhibiting NOX4-NLRP3 signaling in mice." [Biomed. Pharmacother. 150 (2022) 112936].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 01, 2023
Ginsenoside Rg1 attenuates lipopolysaccharide-induced chronic liver damage by activating Nrf2 signaling and inhibiting inflammasomes in hepatic cells.
Journal: Journal of ethnopharmacology
Published: October 04, 2023
Trpc6 knockout protects against renal fibrosis by restraining the CN‑NFAT2 signaling pathway in T2DM mice.
Journal: Molecular medicine reports
Published: August 24, 2023
Interruption of TRPC6-NFATC1 signaling inhibits NADPH oxidase 4 and VSMCs phenotypic switch in intracranial aneurysm.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 06, 2023
Ginsenoside Rg1 alleviates learning and memory impairments and Aβ disposition through inhibiting NLRP1 inflammasome and autophagy dysfunction in APP/PS1 mice.
Journal: Molecular medicine reports
Published: August 09, 2022
Stress level of glucocorticoid exacerbates neuronal damage and Aβ production through activating NLRP1 inflammasome in primary cultured hippocampal neurons of APP-PS1 mice.
Journal: International immunopharmacology
Published: March 31, 2022
Ginsenoside Rg1 attenuates LPS-induced chronic renal injury by inhibiting NOX4-NLRP3 signaling in mice.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 08, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026